Evaluation of inadequate anti-retroviral treatment in patients with HIV/AIDS

Fonseca, Leonardo Carvalho da; Martins, Francislene Juliana; Vieira, Rita de Cássia Padula Alves; Pereira, Rouzeli Maria Coelho; Ferreira, Aline Siqueira; Raposo, Nádia Rezende Barbosa.
Rev. Soc. Bras. Med. Trop ; 45(2): 151-155, Mar.-Apr. 2012. tab
Artículo en Inglés | LILACS | ID: lil-625166

Documentos relacionados

  1. Chemometrics as a valuable tool for evaluating interactions between antiretroviral drugs and food.
  2. Quinolines and isoquinolines as HIV-1 inhibitors: Chemical structures, action targets, and biological activities.
  3. [Current antiretroviral therapy: A review].
  4. Identification of Mechanism and Pathway of the Interaction between the African Traditional Medicine, Sutherlandia Frutescens, and the Antiretroviral Protease Inhibitor, Atazanavir, in Human Subjects Using Population Pharmacokinetic (PK) Analysis.
  5. The effect of protease inhibitors-based antiretroviral therapy on serum/plasma interleukin-6 levels among PLHIV: a systematic review and meta-analysis.
  6. A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children.
  7. [Lopinavir/ritonavir in new initial antiretroviral treatment strategies].
  8. Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV.
  9. Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens.
  10. Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial.